Climb Bio Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +15.1% | +603.3% | -22.1% | -18.2% | +96.6% | -22.8% | |
| – | +3.4% | +573.9% | -9.3% | -18.0% | +40.5% | -31.7% | |
| – | -3.5% | +129.0% | -7.1% | +113.6% | -6.3% | -59.1% | |
| – | -3.5% | +566.2% | -9.5% | -13.6% | +41.3% | -33.0% | |
| – | – | – | -0.5% | -62.0% | -54.6% | – | |
| – | +291.2% | +97.1% | +4.0% | -54.3% | +84.9% | +37.0% | |
| – | +291.2% | +96.9% | +1.1% | -53.5% | +74.1% | +41.6% | |
| – | – | – | – | +11.3% | -53.0% | +63.1% | |
| – | +67.9% | +29.3% | -46.6% | -91.2% | +968.2% | +221.8% | |
| – | +4.6% | +675.2% | -23.0% | -16.4% | +96.9% | -24.3% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +5.1% | +114.6% | +2.6% | +78.5% | +40.8% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.